RIDGEWOOD, N.J. -- The Valley Hospital has received a full, four-year accreditation from the American Society for Radiation Oncology’s (ASTRO) Accreditation Program for Excellence APEx).
Valley’s cancer program holds the distinction of being the only one in New Jersey, and one of seven in the country, to receive this accreditation.
“We are pleased to receive APEx accreditation from ASTRO, the premier radiation oncology society in the world,” said Dr. Chad DeYoung, Co-Director of Radiation Oncology at Valley. “Evaluating our processes in relation to ASTRO’s high standards, including standards for safety and quality, validates our practices and recognizes the efforts of our radiation oncology team to deliver patient-centered radiation oncology care.”
APEx is an independent radiation oncology practice accreditation program founded on evidence-based standards and the five pillars of patient care: the process of care; the radiation oncology team; safety; quality management; and patient-centered care.
To receive accreditation, Valley’s policies and procedures were reviewed for performance in radiation oncology. Valley also demonstrated its commitment to high standards of safety, quality and patient-centered care through effective communication, coordinated treatment and engaging patients and their families as partners in care.
“ASTRO is proud to recognize Valley for achieving APEx accreditation,” said ASTRO chair Dr. Bruce Minsky. “Valley has demonstrated a commitment to providing their patients with safe, high-quality radiation therapy services.”
Valley’s oncology program, which recently partnered with Mount Sinai Health System, provides comprehensive, patient-centered cancer care in northern New Jersey. Valley offers state-of-the-art treatment options for oncology patients, outpatient supportive services, clinical trials and access to Mount Sinai’s renowned experts in the field of cancer care.
For more information, visit Valley's website.